Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;34(12):2243-50.
doi: 10.1007/s11064-009-0022-9.

Oligodendrocytes are a novel source of amyloid peptide generation

Affiliations
Free article

Oligodendrocytes are a novel source of amyloid peptide generation

Stephen D Skaper et al. Neurochem Res. .
Free article

Abstract

Alzheimer’s disease is characterised by regional neuronal degeneration, synaptic loss, and the progressive deposition of the 4 kDa β-amyloid peptide (Aβ) in senile plaques and accumulation of tau protein as neurofibrillary tangles. Aβ derives from the larger precursor molecule, amyloid precursor protein (APP) by proteolytic processing via β- and γ-secretases. While APP expression is well documented in neurons and astrocytes, the case for oligodendrocytes is less clear. The latter cell type is reported to express different isoforms of APP, and we have confirmed this observation by immunocytochemistry in cultures of differentiated rat cortical oligodendrocytes. Moreover, by means of a sensitive electrochemiluminescent immunoassay employing Aβ C-terminal specific antibodies, mature oligodendrocytes are shown to secrete the 40 and 42 amino acid Aβ species (Aβ40 and Aβ42). Secretion of Aβ peptides was reduced by incubating oligodendrocytes with α- and β-secretase inhibitors, or a γ-secretase inhibitor. Disturbances of APP processing and/ or synthesis in oligodendrocytes may account for some myelin disorders observed in Alzheimer's disease and other senile dementias.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

References

    1. J Neurosci. 1997 Oct 1;17(19):7267-77 - PubMed
    1. Nature. 1988 Feb 11;331(6156):530-2 - PubMed
    1. Neuropathol Appl Neurobiol. 1980 Mar-Apr;6(2):119-32 - PubMed
    1. Neuron. 2005 Mar 3;45(5):675-88 - PubMed
    1. J Neurosci. 2002 May 1;22(9):3553-67 - PubMed

Publication types

MeSH terms

Feedback